EP0859842A4 - KURZFORMEN VON CHEMOKIN-g(b)-8 - Google Patents

KURZFORMEN VON CHEMOKIN-g(b)-8

Info

Publication number
EP0859842A4
EP0859842A4 EP96936051A EP96936051A EP0859842A4 EP 0859842 A4 EP0859842 A4 EP 0859842A4 EP 96936051 A EP96936051 A EP 96936051A EP 96936051 A EP96936051 A EP 96936051A EP 0859842 A4 EP0859842 A4 EP 0859842A4
Authority
EP
European Patent Office
Prior art keywords
chemokine
short forms
short
forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP96936051A
Other languages
English (en)
French (fr)
Other versions
EP0859842A1 (de
Inventor
John White
Edward Appelbaum
Daniel O'shannessy
James Allan Fornwald
Kevin O'donnell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP0859842A1 publication Critical patent/EP0859842A1/de
Publication of EP0859842A4 publication Critical patent/EP0859842A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP96936051A 1995-09-29 1996-09-27 KURZFORMEN VON CHEMOKIN-g(b)-8 Withdrawn EP0859842A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US451795P 1995-09-29 1995-09-29
US604517 1995-09-29
PCT/US1996/015592 WO1997012041A1 (en) 1995-09-29 1996-09-27 SHORT FORMS OF CHEMOKINE β-8

Publications (2)

Publication Number Publication Date
EP0859842A1 EP0859842A1 (de) 1998-08-26
EP0859842A4 true EP0859842A4 (de) 1999-02-24

Family

ID=21711157

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96936051A Withdrawn EP0859842A4 (de) 1995-09-29 1996-09-27 KURZFORMEN VON CHEMOKIN-g(b)-8

Country Status (16)

Country Link
EP (1) EP0859842A4 (de)
JP (1) JPH11512610A (de)
KR (2) KR19990063834A (de)
CN (2) CN1198186A (de)
AU (1) AU711573B2 (de)
BG (1) BG102413A (de)
BR (1) BR9610671A (de)
CZ (1) CZ92198A3 (de)
EA (1) EA199800352A1 (de)
HU (1) HUP9802699A3 (de)
NO (1) NO981387L (de)
NZ (1) NZ320932A (de)
PL (1) PL326080A1 (de)
TR (1) TR199800575T1 (de)
WO (1) WO1997012041A1 (de)
ZA (1) ZA968204B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6811773B1 (en) 1993-12-22 2004-11-02 Human Genome Sciences, Inc. Human monocyte colony inhibitory factor (M-CIF) polypeptides
US6001606A (en) * 1994-03-08 1999-12-14 Human Genome Sciences, Inc. Polynucleotides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) and polypeptides encoded thereby
US6488925B2 (en) 1993-12-22 2002-12-03 Human Genome Sciences, Inc. Macrophage inflammatory protein-4 (MIP-4) polypeptides
US6623942B2 (en) 1994-03-08 2003-09-23 Human Genome Sciences, Inc. Macrophage inflammatory protein-4 (MIP-4) polynucleotides
US6495129B1 (en) 1994-03-08 2002-12-17 Human Genome Sciences, Inc. Methods of inhibiting hematopoietic stem cells using human myeloid progenitor inhibitory factor-1 (MPIF-1) (Ckbeta-8/MIP-3)
KR20030097607A (ko) * 1996-09-30 2003-12-31 휴먼 게놈 사이언시즈, 인코포레이티드 골수양 선조 세포 억제 인자-1(ｍｐｉｆ-1)를 이용하여질병 상태를 치료하기 위한 치료 조성물 및 치료 방법
KR19990042713A (ko) * 1997-11-27 1999-06-15 허일섭 사람에서 분리한 c 6 베타-케모카인 lkn-1의 cdna 및 재조합 lkn-1의 제조방법
WO2001036459A2 (en) * 1999-11-15 2001-05-25 Forssmann Wolf Georg Novel use of hcc-2
US20030215460A1 (en) * 2002-05-07 2003-11-20 Schall Thomas J. Methods and compositions for inducing an immune response

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995017092A1 (en) * 1993-12-22 1995-06-29 Human Genome Sciences, Inc. MACROPHAGE INFLAMMATORY PROTEINS-3, -4 AND -1¿η?
WO1996034891A1 (en) * 1995-05-05 1996-11-07 Human Genome Sciences, Inc. Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
WO1997015594A1 (en) * 1995-10-24 1997-05-01 Smithkline Beecham Corporation Novel chemokine for mobilizing stem cells
EP0807439A2 (de) * 1996-05-14 1997-11-19 Smithkline Beecham Corporation Verfahren zur behandlung von sepsis und atemnotsyndrom bei erwachsenen

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995017092A1 (en) * 1993-12-22 1995-06-29 Human Genome Sciences, Inc. MACROPHAGE INFLAMMATORY PROTEINS-3, -4 AND -1¿η?
WO1996034891A1 (en) * 1995-05-05 1996-11-07 Human Genome Sciences, Inc. Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
WO1997015594A1 (en) * 1995-10-24 1997-05-01 Smithkline Beecham Corporation Novel chemokine for mobilizing stem cells
EP0807439A2 (de) * 1996-05-14 1997-11-19 Smithkline Beecham Corporation Verfahren zur behandlung von sepsis und atemnotsyndrom bei erwachsenen

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9712041A1 *

Also Published As

Publication number Publication date
NO981387L (no) 1998-05-29
ZA968204B (en) 1997-04-09
WO1997012041A1 (en) 1997-04-03
AU711573B2 (en) 1999-10-14
AU7379096A (en) 1997-04-17
PL326080A1 (en) 1998-08-17
HUP9802699A2 (hu) 1999-03-29
KR19990063834A (ko) 1999-07-26
CN1198186A (zh) 1998-11-04
NZ320932A (en) 2000-01-28
CZ92198A3 (cs) 1998-07-15
BG102413A (bg) 1999-04-30
HUP9802699A3 (en) 2000-09-28
CN1405180A (zh) 2003-03-26
BR9610671A (pt) 1999-07-06
MX9802380A (es) 1998-08-30
TR199800575T1 (en) 1998-06-22
KR20030096447A (ko) 2003-12-31
EA199800352A1 (ru) 1998-12-24
NO981387D0 (no) 1998-03-26
JPH11512610A (ja) 1999-11-02
EP0859842A1 (de) 1998-08-26

Similar Documents

Publication Publication Date Title
PL322277A1 (en) Derivatives of pyrazol-4-ylobenzoyl
GB9503240D0 (en) Preparation
GB9526560D0 (en) Use of 2-Amino-Heterocycles
PL324451A1 (en) Derivatives of diphenylmethylenepiperidine
PL321686A1 (en) Trensdermal preparation
IL116924A (en) Preparation of n-aryl - and n-hetarylhydroxylamines
ZA96725B (en) Use of phenyclyclohexylcarboxamides
EP0859842A4 (de) KURZFORMEN VON CHEMOKIN-g(b)-8
PL320114A1 (en) Phenyl-substituted fluoroderivatives of 4-azasteroides
DE69637797D1 (en) Ten)phenylazoresorcinolen
IL117786A (en) Preparation of alpha-bisoximes
AP9600802A0 (en) Libricant
EP0723052A3 (de) Handlauf
ZA962440B (en) Destressing of railtracks
PL313849A1 (en) Beta-aminoesters of o-hydrobenzylamides
GB9502637D0 (en) Reduction
TW318352U (en) Structure of bed-lifting (addition one)
GB9514072D0 (en) Preparation of thionucleosides
GB2303388B (en) Handrail
IL115554A0 (en) Earthquake-proofing of structures
HU9503668D0 (en) Attaching means of hooses
IL117844A0 (en) Use of (s)-adenosyl-l-methionine
HRP950468A2 (en) New medicine - combination of components
GB9512234D0 (en) Icositetrahedron shaped part
TW358610U (en) Improvement of inter-com

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980428

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL PAYMENT 980428;LT PAYMENT 980428;LV PAYMENT 980428;SI PAYMENT 980428

RTI1 Title (correction)
A4 Supplementary search report drawn up and despatched

Effective date: 19990111

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RA4 Supplementary search report drawn up and despatched (corrected)

Effective date: 19990215

17Q First examination report despatched

Effective date: 20020528

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20041103